Home > Specialties > Reagents, Immunoassay, Tumor Marker, Protein, Chromogranin A

Reagents, Immunoassay, Tumor Marker, Protein, Chromogranin A

Definition : Immunoassay reagents intended to perform qualitative and/or quantitative analyses on a body fluid sample (e.g., serum) to determine chromogranin A (CgA), a soluble protein secreted by the adrenal medulla. CgA is a sensitive and specific tumor marker for various types of neuroendocrine tumors, its determination is mostly used as a general tumor marker in some carcinoid and endocrine pancreatic tumors without clinical hormone-related symptoms (i.e., nonfunctioning tumors). The determination of the CgA level is also used as a serum marker for diagnosis and therapeutic monitoring in patients with neuroendocrine tumors.

Entry Terms : "Chromogranin A (CgA) Determination Reagents" , "CgA (Chromogranin A) Determination Reagents"

UMDC code : 19854

   

1-3 of 3 Match(es).

ALPCO Diagnostics

ALPCO distributed one product in the United States. Within a decade of its founding, ALPCO partnered with more than 40 manufactures and grew its distribution network throughout North America. To further meet the needs of its customers, ALPCO expanded in 2004 with the advent of its Research and Development Division. Within three years, ALPCO launched its first line of organically developed enzyme-linked immunosorbent assay (ELISA) kits for insulin. Since then, ALPCO has solidified its place in the domestic and international markets not only as a distributor, but also as a developer and manufacturer of immunoassays.

Quartett Immunodiagnostika und

Quartett Immunodiagnostika und

Ventana Medical Systems Inc

Ventana Medical Systems, Inc., was launched in 1987 by a professor and practicing pathologist, Dr. Thomas Grogan. Ventana Medical Systems, Inc., a member of the Roche Group, is a world leader and innovator of tissue-based diagnostic solutions for patients worldwide.

1-3 of 3 Match(es).

 

Medical Product Guide Optometric Management Product Guide